The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM), which spurred excitement over a potential $20 billion ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Pfizer's CEO certainly thinks so. In a TV interview, Bourla said: "Pfizer, when it plays, plays big. And we will -- as we did in COVID, as we did with Lipitor, as we did with ... Viagra, as we did ...
Billionaires and the hedge funds they manage bought millions of Pfizer shares in the third quarter. Shares of Pfizer are down by nearly half since the end of 2022. Pfizer faces significant patent ...
In what CEO Albert Bourla, Ph.D., called an update to a top priority at Pfizer, the company on Thursday systemically laid out its new oncology strategy following the $43 billion acquisition of ...
After losing nearly half its value from its 2021 highs, Pfizer stock (NYSE: PFE) now trades at about $25, presenting a potentially attractive value setup. As the company continues to adapt to a ...
Pfizer is fattening its drug portfolio by betting that more people will want to slim down. The New York drugmaker announced Monday that it’s acquiring Metsera, and its portfolio of four medications ...
GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff ...
I reaffirm my Buy rating on Pfizer due to expected promising updates on danuglipron and strong capital efficiency metrics, despite the recent stock pullback. Pfizer's management is expected to ...
Pfizer Global Supply features 36 manufacturing sites, 11 distribution and logistics centers, and 31,000 manufacturing and distribution workers. Scale is a primary way Pfizer has been rising to supply ...
Pfizer CEO Albert Bourla appeared on ABC's "This Week." Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who ...